Latest News

BOSTON SCIENTIFIC CORPORATION: Boston Scientific Closes Acquisition of Augmenix, Inc.

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Augmenix, Inc., a privately-held company that developed and commercialized the SpaceOAR® Hydrogel System to help reduce common and debilitating side effects that men may experience after receiving radiotherapy to treat prostate cancer.

ALKU: ALKU's ERP Division Expands to Include ServiceNow Contract Oppurtunities

ALKU a highly specialized consulting services firm, has expanded their niche industries to include ServiceNow contract services.

BOSTON SCIENTIFIC CORPORATION: Boston Scientific Announces Agreement To Acquire Augmenix, Inc.

Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Augmenix, Inc., a privately-held company which has developed and commercialized the SpaceOAR® System, a therapy used to reduce common and debilitating side effects that men may experience after receiving prostate cancer radiotherapy.

Metro Business Network